The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

Podcasts
Jeff Berman, Principal and Healthcare Supply Chain Practice Leader at Grant Thornton, discusses emerging trends in the health care supply chain due…
Press Releases
CHICAGO, July 23, 2020 — In partnership with the Association for Health Care Resource & Materials Management (AHRMM) of the American Hospital A
On-Demand Educational Webinars
Supply chain leaders share their processes and experiences in managing non-labor and non-personnel expenses.
On-Demand Educational Webinars
Provider panelists discuss their post-pandemic approach to their business continuity programs, working with non-traditional buyers, diversifying…
Podcasts
Michael Brown, Director of Supply Chain Management and Eric Swaim, Manager of Strategic Sourcing and Vendor Management at Texas Children’s Hospital…